Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
  Onyx Biotec Ltd
Registered Office: Bir Plassi Near Sainimajraropr,Nalagarh Rd Dist Solan , Solan - 174101 , Himachal Pradesh , India.
Phone : +91 172 265 6384   Fax:
Email :  generalinfo@onyxbiotec.com  
Website :  www.onyxbiotec.com
Initial public offer of upto 48,10,000 equity shares of face value of 10/- each ("Equity Shares") of the company at an issue price of 61 per equity share (including a share premium of 51 per equity share) for cash, aggregating up to 29.34 crores ("Public Issue") out of which 2,44,000 equity shares of face value of 10/- each, at an issue price of 61 per equity share for cash, aggregating 1.49 crores will be reserved for subscription by the market maker to the issue (the "Market Maker Reservation Portion"). The public issue less market maker reservation portion i.e. issue of 45,66,000 equity shares of face value of 10/- each, at an issue price of 61 per equity share for cash, aggregating up to 27.85 crores is hereinafter referred to as the "Net Issue". The public issue and net issue will constitute 26.53 % and 25.18 % respectively of the post-issue paid-up equity share capital of the company.

Issue Money Payable On
Opens On Closes On Application Allotment
13-Nov-24 18-Nov-24 Rs61.00-0.00 Rs0.00-0.00
Minimum Application for shares in Nos :2000  Further Multiples of :2000

  RsCr Lead Managers to the Issue
Project Cost 0.00
Horizon Management Pvt Ltd
Project Financed through Current Offer 29.34  
Post Issue Equity Share Capital 18.13  
Issue Price Rs61.00  
 
Projects
 Upgradation of existing mfg unit 1 to mfg large volume parentals for intravenous use Prepayment or repayment of all or a portion of certain loans availed by the company
 Setting up a high-speed cartooning packaging line at existing mfg unit 2 for Dry Powder Injections General corporate purposes
Promoted By
 Sanjay Jain
 Naresh Kumar
 Fateh Pal Singh
Listing At
 NSE - SME 
Registrar to the Issue
 Mas Services Limited